Table of contents of journal:

Results: 13

Cholesterol-lowering clinical trials - A historical perspective

Authors: Grundy, SM

Citation: Sm. Grundy, Cholesterol-lowering clinical trials - A historical perspective, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 1-44

The Scandinavian simvastatin survival study (4S)

Authors: Pedersen, TR

Citation: Tr. Pedersen, The Scandinavian simvastatin survival study (4S), CHOLESTEROL-LOWERING THERAPY, 2000, pp. 45-62

Cholesterol and recurrent events trial (CARE) - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels

Authors: Sacks, FM Pfeffer, MA Moye, LA Hawkins, CM Davis, BR Rouleau, JL Cole, TG Braunwald, E

Citation: Fm. Sacks et al., Cholesterol and recurrent events trial (CARE) - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 63-89

Lessons from the West of Scotland Coronary Prevention Study (WOSCOPS)

Authors: Shepherd, J Gaw, A

Citation: J. Shepherd et A. Gaw, Lessons from the West of Scotland Coronary Prevention Study (WOSCOPS), CHOLESTEROL-LOWERING THERAPY, 2000, pp. 91-116

Program on the surgical control of the hyperlipidemias (POSCH) trial - A pivotal 25-year study

Authors: Buchwald, H

Citation: H. Buchwald, Program on the surgical control of the hyperlipidemias (POSCH) trial - A pivotal 25-year study, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 117-149

The air force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS) - Primary prevention of acute major coronary events in men and women with average cholesterol

Authors: Weis, S Clearfield, M Downs, JR Gotto, AM

Citation: S. Weis et al., The air force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS) - Primary prevention of acute major coronary events in men and women with average cholesterol, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 151-172

Long-term intervention with Pravastatin in Ischemic Disease (LIPID) study - Clinical implications for cardiovascular practice

Authors: Tonkin, AM Hunt, D

Citation: Am. Tonkin et D. Hunt, Long-term intervention with Pravastatin in Ischemic Disease (LIPID) study - Clinical implications for cardiovascular practice, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 173-190

Angiographic results of lipid-lowering trials - A systematic review and meta-analysis

Authors: Holmes, CL Schulzer, M Mancini, GBJ

Citation: Cl. Holmes et al., Angiographic results of lipid-lowering trials - A systematic review and meta-analysis, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 191-220

Biochemical correlates of plaque progression and coronary events

Authors: Ferraro-Borgida, M Waters, D

Citation: M. Ferraro-borgida et D. Waters, Biochemical correlates of plaque progression and coronary events, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 221-247

Lipid therapy to stabilize the vulnerable atherosclerotic plaque - New insights into the prevention of cardiovascular events

Authors: Brown, BG Zhao, XQ

Citation: Bg. Brown et Xq. Zhao, Lipid therapy to stabilize the vulnerable atherosclerotic plaque - New insights into the prevention of cardiovascular events, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 249-272

Cholesterol-lowering trials with carotid ultrasonographic outcomes

Authors: Byington, RP

Citation: Rp. Byington, Cholesterol-lowering trials with carotid ultrasonographic outcomes, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 273-298

Cholesterol lowering reduces mortality - The statins

Authors: Gordon, DJ

Citation: Dj. Gordon, Cholesterol lowering reduces mortality - The statins, CHOLESTEROL-LOWERING THERAPY, 2000, pp. 299-311

Cholesterol-lowering therapy - Evaluation of clinical trial evidence - Foreword

Authors: Lenfant, C

Citation: C. Lenfant, Cholesterol-lowering therapy - Evaluation of clinical trial evidence - Foreword, CHOLESTEROL-LOWERING THERAPY, 2000, pp. III-IV

Risultati: 1-13 |